Published: Oct 09, 2026
Updated: Oct 09, 2026

Liver transplantation can save lives for individuals who have severe liver disease, liver failure, or some forms of liver cancer. A large number of patients and families ask, "Where is the liver coming from?
Today, doctors can perform liver transplants using a liver from either a living donor or a deceased donor. Advances in surgery, organ preservation, imaging, and patient management have made transplants safer and more accessible.
Each person's liver transplant team needs to understand the differences between living and deceased donor liver transplantation so they can help the patient and their caregivers make informed decisions and discuss the best course of action.
A liver transplant is a surgical procedure in which a diseased liver is replaced with healthy liver tissue from a donor. Doctors may recommend it when the liver is severely damaged and can no longer perform its normal functions.
A liver transplant may be considered for conditions such as:
The liver is a unique organ because it can regenerate, which makes living donor liver transplantation possible.
Living donor liver transplantation is performed by removing a part of the liver from a living person who is healthy and by taking consent from a relative or approved donor. The liver tissue regenerates in both the donor and recipient within a few weeks. This is the most common transplant procedure in India, as there is a shortage of deceased donor organs.
Donors may be family members, relatives, friends, or, in some cases, unrelated individuals who meet legal and medical criteria.
Before donating, potential donors go through a thorough medical checkup that may include:
Living liver donation is a major surgery, and keeping donors safe is the most important concern throughout the process.
In a deceased donor liver transplant (DDLT), the liver comes from a person who donated organs after death. The organ is allocated based on medical urgency, compatibility, and transplant regulations.
In some instances, splitting the liver will allow a donated liver to be divided and transplanted into multiple recipients. The whole liver or one part of the liver can be allocated to two persons through the state or national organ-sharing waitlist according to the level of medical urgency (MELD score) and blood group match. Patients who do not have a living donor are a suitable group for deceased donor transplantation.
Feature | Living Donor Liver Transplant (LDLT) | Deceased Donor Liver Transplant (DDLT) |
donor | A healthy living person donates a portion of their liver. | The liver is donated after the donor's death. |
Liver used | Only the required portion of the donor's liver is transplanted. | Usually the whole liver is transplanted. |
Waiting time
| May be planned after the required evaluation and approval process | Depends on the availability of a suitable deceased donor organ and the applicable allocation system |
Surgery for donor
| The donor undergoes a major surgical procedure to remove part of the liver. | No living donor surgery required. |
Liver regeneration | After transplantation, the donated liver portion can be regenerated. | The transplanted liver can also grow and adapt to the recipient's body |
Risk | Involves surgical risks for both the donor and recipient. Donor safety is carefully assessed before donation. | There are no surgical risks to a living donor, but the recipient remains at risk of complications associated with transplantation. |
Legal process | Requires informed consent, detailed donor evaluation, and compliance with applicable organ-donation laws and authorisation procedures. | Can be allocated through the state or national organ-sharing waitlist based on medical urgency (MELD score). |
Planning | The procedure can generally be planned after the donor and recipient have been evaluated and approved. | The timing depends on when a suitable donor organ becomes available. |
Liver transplantation has changed significantly over the past few decades. Modern technologies improve donor safety, preserve donor organs more effectively, and help doctors personalise treatment.
Traditionally, living donor surgery required a large incision. Today, some transplant centres use laparoscopic or robotic-assisted techniques in carefully selected donors:
However, these techniques are not suitable for every donor and require highly experienced surgical teams.
Modern CT scans, MRI scans, and 3D imaging help doctors carefully study the liver before surgery.
These technologies can help:
More precise planning may reduce complications and improve surgical outcomes.
Living donor liver transplantation (LDLT) is increasingly considered in complex cases, including liver retransplantation or advanced liver cancers. It is available as a substitute if a suitable dead donor liver is not available in time. The criteria for eligibility are the patient's condition, diagnosis of cancer, suitability of the donor and assessment by the transplant centre.
The use of machine perfusion in advanced organ preservation benefits deceased donor transplantation by keeping the donated liver under controlled conditions outside the body. Depending on the method, the machine supplies oxygen and nutrients or provides controlled cooling. This can improve organ preservation, allow evaluation of liver function before transplantation, and possibly make some otherwise unsuitable organs usable.
In selected cases, a deceased-donor liver can be split into two grafts and transplanted into two recipients, often an adult and a child. Whether a liver is suitable for splitting depends on donor characteristics, liver anatomy, graft size and the needs of the intended recipients. Deceased-donor organs are allocated through the applicable national, regional and state transplant systems according to medical urgency and other allocation criteria.
Like any major surgery, liver transplantation carries risks.
As with other transplant surgeries, recovery varies from person to person.
For Recipients
After surgery, patients typically spend time in the intensive care unit and hospital. Recovery can take several months and requires regular follow-up visits. Most patients also need long-term immunosuppressive medications and monitoring.
For Living Donors
Living donors also need time to recover from major surgery. After receiving medical clearance, many gradually resume normal activities, though recovery times vary.
Living donor and deceased donor liver transplants both play a vital role in saving lives. The betterment of outcomes for both donor and recipient is aided by improved imaging techniques, minimally invasive surgery, machine perfusion, and personalised care.
There is no one-size-fits-all solution for transplants. This depends on the patient's health, donor availability, and the transplant team's experience. Liver transplantation is evolving, with ongoing innovation, thoughtful patient selection, and a commitment to donor safety, offering hope to those who have life-threatening liver disease.
References
Living donation requires major surgery and carries risks, including bleeding, infection, bile leakage, and blood clots. Donors undergo thorough medical and psychological evaluations to confirm that donation is appropriate and to prioritize their safety.
Most people who receive a liver transplant need immunosuppressive medicines to lower the risk of rejection. Doctors adjust the medicines and doses to each patient's needs and response.
The choice depends on your medical condition, urgency, donor availability, blood group, liver anatomy, and other clinical factors. A transplant team evaluates these factors before recommending an appropriate option.
Most liver transplant recipients need immunosuppressive medicines to reduce the risk of rejection. The medicines and doses are adjusted according to the patient's individual needs and response.
Wait times vary based on disease severity, blood type, organ availability, and the allocation system through the state or national organ-sharing waitlist based on medical urgency (MELD score). There is no set waiting period for everyone.

Pragun Gupta is a Doctor of Pharmacy (Pharm. D.) professional from Teerthanker Mahaveer University with hands-on experience in clinical pharmacology, clinical research, and evidence-based medical writing. Through her clinical and research exposure, she has developed a strong interest in pharmacoeconomics, pharmacology, therapeutics, and pharmacovigilance. As a medical writer, she works on medical and scientific research articles, patient education materials, and healthcare-focused content. Her clinical research and evidence-based writing experience enables her to translate complex medical information into clear, accurate, patient-friendly content while maintaining scientific credibility and medical accuracy. Her primary aim is to make healthcare information accessible and easy for patients and general readers to understand.

Dr. Akash Khandelwal is a distinguished Haematologist, Hemato-oncologist, and Bone Marrow Transplant (BMT) Physician with extensive training from the prestigious AIIMS New Delhi. His expertise encompasses a wide range of specialized techniques in bone marrow transplantation, including autologous and allogeneic transplants such as matched sibling donors, matched unrelated donors (MUD), and haploidentical donor transplants. Dr. Khandelwal has personally supervised and conducted over 100 bone marrow transplants.





Delhi, India

Istanbul, Turkey

Istanbul, Turkey

Istanbul, Turkey